VIIV HEALTHCARE PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

A Study To Evaluate An Interaction Between Maraviroc And Raltegravir In Healthy Subjects

Phase 4
Completed
Conditions
Healthy
Interventions
Drug: Maraviroc
Drug: Raltegravir
First Posted Date
2008-04-25
Last Posted Date
2013-01-25
Lead Sponsor
ViiV Healthcare
Target Recruit Count
18
Registration Number
NCT00666705
Locations
🇺🇸

Pfizer Investigational Site, New Haven, Connecticut, United States

Prospective Observational Epidemiologic Study of Maraviroc's Safety

First Posted Date
2008-04-24
Last Posted Date
2022-10-18
Lead Sponsor
ViiV Healthcare
Target Recruit Count
2500
Registration Number
NCT00665561
Locations
🇺🇸

Providence Clinical Research, Burbank, California, United States

🇺🇸

LA Gay and Lesbian Center, Los Angeles, California, United States

🇺🇸

The McGregor Clinic, Fort Myers, Florida, United States

and more 262 locations

Pharmacokinetics, Pharmacodynamics, And Safety Of Maraviroc (UK-427,857) In Patients With Human Immunodeficiency Virus

Phase 2
Completed
Conditions
HIV Infections
Interventions
Drug: Maraviroc (UK-427,857)
Other: Placebo
First Posted Date
2008-03-26
Last Posted Date
2010-11-10
Lead Sponsor
ViiV Healthcare
Target Recruit Count
41
Registration Number
NCT00643643
Locations
🇬🇧

Pfizer Investigational Site, London, United Kingdom

Effects Of Food And Dose Regimen On The Antiviral Effects Of Maraviroc (UK-427,857) In Patients With Human Immunodeficiency Virus

Phase 2
Completed
Conditions
HIV
Interventions
Drug: Maraviroc (UK-427,857)
Other: Placebo
First Posted Date
2008-03-13
Last Posted Date
2010-11-10
Lead Sponsor
ViiV Healthcare
Target Recruit Count
37
Registration Number
NCT00634959
Locations
🇬🇧

Pfizer Investigational Site, London, United Kingdom

GSK1349572 Repeat Dose Escalation and Relative Bioavailability Study

Phase 1
Completed
Conditions
Healthy Subjects
Interventions
Drug: GSK1349572
First Posted Date
2008-03-07
Last Posted Date
2017-02-03
Lead Sponsor
ViiV Healthcare
Target Recruit Count
44
Registration Number
NCT00631592
Locations
🇺🇸

GSK Investigational Site, Madison, Wisconsin, United States

Multicenter Pilot Study To Define The Marker As An Alternate For Tropism Assay

First Posted Date
2007-07-04
Last Posted Date
2019-01-30
Lead Sponsor
ViiV Healthcare
Target Recruit Count
16
Registration Number
NCT00496782
Locations
🇨🇦

Pfizer Investigational Site, Montreal, Quebec, Canada

Multicenter, Safety Study Of Maraviroc

First Posted Date
2007-05-24
Last Posted Date
2011-09-09
Lead Sponsor
ViiV Healthcare
Target Recruit Count
209
Registration Number
NCT00478231
Locations
🇧🇷

Pfizer Investigational Site, São Paulo, SP, Brazil

Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701

First Posted Date
2007-03-29
Last Posted Date
2017-09-12
Lead Sponsor
ViiV Healthcare
Target Recruit Count
1502
Registration Number
NCT00453440
Locations
🇬🇧

GSK Investigational Site, London, United Kingdom

HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults

First Posted Date
2007-03-22
Last Posted Date
2012-06-07
Lead Sponsor
ViiV Healthcare
Target Recruit Count
212
Registration Number
NCT00450580
Locations
🇬🇧

GSK Investigational Site, London, United Kingdom

Prospective Epidemiological Study Of The Prevalence Of HLAB*5701 In HIV-1 Infected Patients

Phase 4
Completed
Conditions
Infection, Human Immunodeficiency Virus
Interventions
Drug: GI265235
First Posted Date
2007-03-01
Last Posted Date
2017-08-22
Lead Sponsor
ViiV Healthcare
Target Recruit Count
974
Registration Number
NCT00441688
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy